# Amgen Inc. (AMGN) — Q4-2016 Earnings Results

**Report date:** 2017-02-02 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/AMGN/earnings/Q4-2016

## Post-Earnings Brief

### Headline

Amgen Beats on EPS, Stock Down 0.06%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.89 | N/A | +4.26% |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed satisfaction with the EPS results, highlighting their commitment to shareholder value. However, no specific guidance was provided for future performance.

**Key quotes:**

> We are pleased with our EPS performance this quarter.

> Our focus remains on delivering value to our shareholders.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Amgen's earnings report showed a positive surprise in EPS, indicating better-than-expected profitability. However, the stock experienced a slight decline of 0.06%, suggesting that investors may have been looking for more comprehensive guidance or additional insights into future performance. The lack of revenue data and guidance may have contributed to the muted stock reaction.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/AMGN/earnings/Q4-2016_